Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Interest Expenses (2016 - 2022)

Historic Interest Expenses for Niagen Bioscience (NAGE) over the last 14 years, with Q3 2022 value amounting to $5000.0.

  • Niagen Bioscience's Interest Expenses fell 6666.67% to $5000.0 in Q3 2022 from the same period last year, while for Jun 2023 it was $5000.0, marking a year-over-year decrease of 8809.52%. This contributed to the annual value of $55000.0 for FY2021, which is 2253.52% down from last year.
  • Latest data reveals that Niagen Bioscience reported Interest Expenses of $5000.0 as of Q3 2022, which was down 6666.67% from $10000.0 recorded in Q2 2022.
  • In the past 5 years, Niagen Bioscience's Interest Expenses registered a high of $575000.0 during Q2 2019, and its lowest value of -$22000.0 during Q4 2018.
  • Moreover, its 5-year median value for Interest Expenses was $15000.0 (2021), whereas its average is $65588.2.
  • As far as peak fluctuations go, Niagen Bioscience's Interest Expenses crashed by 15000.0% in 2018, and later soared by 338888.89% in 2019.
  • Niagen Bioscience's Interest Expenses (Quarter) stood at -$22000.0 in 2018, then surged by 68.18% to -$7000.0 in 2019, then skyrocketed by 328.57% to $16000.0 in 2020, then plummeted by 43.75% to $9000.0 in 2021, then tumbled by 44.44% to $5000.0 in 2022.
  • Its Interest Expenses stands at $5000.0 for Q3 2022, versus $10000.0 for Q2 2022 and $8000.0 for Q1 2022.